Schulman

Scientists at the Max Planck Institute of Biochemistry (MPIB) decipher the activation chain of protein degradation more

Brenda Schulman, head of the department "Molecular Machines and Signaling" at the Max Planck Institute of Biochemistry has been elected member of the German National Academy of Sciences Leopoldina. more

Brenda Schulman, head of the department "Molecular Machines and Signaling" at the Max Planck Institute for Biochemistry in Martinsried, receives the Ernst Jung Prize for Medicine 2019 together with the neurobiologist Gary R. Lewin from Berlin. The prize money of 300,000 euros is shared equally. Brenda Schulman receives the award in recognition and continuation of her groundbreaking work on the mechanisms of ubiquitin transfer at the atomic level. The Ernst Jung Prize will be awarded today in Hamburg. more

Brenda Schulman, head of the department „Molecular Machines and Signaling“ at the Max Planck Institute of Biochemistry in Martinsried receives the Gottfried Wilhelm Leibniz Prize 2019. It comes with a funding of 2.5 million Euros. The Leibniz Prize honors her important work on the molecular mechanisms of the Ubiquitin System. „I am extremely honored to receive this award and I would like to express my deepest gratitude to the DFG and the selection committee“, says Schulman. The Leibniz-Prize will be awarded on March 13, 2019 in Berlin. more

Today, the European Molecular Biology Organization, EMBO announced Brenda Schulman as a new EMBO member.  Since 2016, Schulman has been a Director at the Max Planck Institute of Biochemistry in Martinsried. „It is a great honor to be elected as a member of EMBO, and this recognition is an exceptionally warm welcome by the European molecular biology community“ says Schulman.  As among the 62 newly elected EMBO Members, Schulman joins a group of more then 1800 outstanding life scientists from Europe and around the world. With the admission of Brenda Schulman, all Directors of the MPI of Biochemistry are now EMBO members. more